Revance Therapeutics Inc (NASDAQ:RVNC)

24.55
Delayed Data
As of 4:00pm ET
 +0.16 / +0.66%
Today’s Change
11.27
Today|||52-Week Range
30.00
+50.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues2.4M487.0K278.0K0.00
 
 
 
 
Depreciation And Amortization444.0K475.0K628.0K790.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------790.0K
 
 
General Expenses35.6M38.4M36.3M38.3M
 
 
 
 
 
Research And Development21.8M25.5M24.0M25.5M
 
 
 
 
 
Total Operating Expenses36.0M38.9M36.9M39.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.6M-38.4M-36.6M-39.1M
 
 
 
 
 
Extraordinary Credit0.0010.0K--21.0K
 
 
 
Extraordinary Charge-45.0K0.00-92.0K0.00
 
 
 
Other Expenses-144.0K-147.0K-155.0K115.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.8M-37.6M-35.3M-37.4M
 
 
 
 
 
Income Taxes0.00-3.0M0.000.00
 
 
Net Income-32.8M-40.6M-35.3M-37.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.3M36.3M41.6M43.3M
 
 
 
 
 
Shares To Calculate EPS Diluted36.3M36.3M41.6M43.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.91-$1.12-$0.85-$0.86
 
 
 
 
 
EPS Diluted-$0.91-$1.12-$0.85-$0.86